Pharmaceutics and Drug Safety

Vaccine Development and Immunopharmacology

Vaccine development and immunopharmacology are critical areas in modern healthcare, focusing on the prevention and treatment of infectious and immune-related diseases through the modulation of the immune system. This session explores the scientific principles and technological advancements involved in designing safe and effective vaccines, including traditional approaches such as live-attenuated and inactivated vaccines, as well as newer platforms like recombinant, vector-based, and nucleic acid vaccines. The session will highlight the role of immunopharmacology in understanding immune responses, antigen presentation, and the mechanisms by which vaccines stimulate protective immunity. Advances in adjuvant systems and delivery technologies are enhancing vaccine efficacy and duration of protection, while reducing side effects. The development process, including preclinical studies, clinical trials, and regulatory approval, will be discussed to provide a comprehensive understanding of the pathway from research to market. Special attention will be given to challenges such as vaccine stability, cold chain requirements, and large-scale manufacturing. The session will also address emerging trends such as personalized vaccines, therapeutic vaccines for chronic diseases, and rapid vaccine development strategies in response to global health emergencies. Safety monitoring and post-marketing surveillance are essential components in ensuring public confidence and long-term effectiveness. Additionally, the integration of advanced technologies and global collaboration is accelerating innovation in this field. This session aims to provide valuable insights into how vaccine development and immunopharmacology contribute to disease prevention, public health, and the advancement of modern medicine.